United States Biotechnology & Medical Research

Champions Oncology Inc (CSBR)

Track

Ticker: CSBR Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Champions Oncology Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Buy 12 Jan 2024
Value US$2,557,031.97 | Price 489.69 | Shares 76,623 (+10.6%)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2024-01-16 2024-01-12 B Purchase
2.7
Mendelson Daniel Newman
Non-Executive Director
76,623 +10.6%
489.69
US$2,557,032 		76,623 +10.6% 489.69 US$2,557,032
2024-01-12 2024-01-11 B Purchase
2.7
Mendelson Daniel Newman
Non-Executive Director
86,089 +28.4%
170.90
US$2,626,279 		86,089 +28.4% 170.90 US$2,626,279
2024-01-11 2024-01-10 B Purchase
2.7
Mendelson Daniel Newman
Non-Executive Director
46,453 +43.9%
23.44
US$4,244,291 		46,453 +43.9% 23.44 US$4,244,291
2024-01-10 2024-01-09 B Purchase
2.7
Mendelson Daniel Newman
Non-Executive Director
3,000 +1.6%
6.25
US$18,750 		3,000 +1.6% 6.25 US$18,750
2024-01-09 2024-01-08 B Purchase
2.7
Mendelson Daniel Newman
Non-Executive Director
1,000 +0.5%
6.15
US$6,150 		1,000 +0.5% 6.15 US$6,150
2024-01-08 2024-01-05 B Purchase
2.7
Mendelson Daniel Newman
Non-Executive Director
2,000 +1.1%
6.09
US$12,180 		2,000 +1.1% 6.09 US$12,180
2024-01-08 2024-01-04 B Purchase
2.7
Mendelson Daniel Newman
Non-Executive Director
3,000 +1.6%
6.12
US$18,360 		3,000 +1.6% 6.12 US$18,360
2024-01-04 2024-01-03 B Purchase
2.7
Mendelson Daniel Newman
Non-Executive Director
500 +0.3%
5.83
US$2,915 		500 +0.3% 5.83 US$2,915
2023-12-26 2023-12-21 B Purchase
2.7
Mendelson Daniel Newman
Non-Executive Director
2,500 +1.4%
4.92
US$12,300 		2,500 +1.4% 4.92 US$12,300
2023-12-21 2023-12-20 B Purchase
2.7
Mendelson Daniel Newman
Non-Executive Director
2,100 +1.2%
4.82
US$10,122 		2,100 +1.2% 4.82 US$10,122
2023-12-20 2023-12-19 B Purchase
2.7
Mendelson Daniel Newman
Non-Executive Director
5,000 +2.9%
4.75
US$23,750 		5,000 +2.9% 4.75 US$23,750
2023-10-13 2023-10-11 B Purchase
2.7
Mendelson Daniel Newman
Non-Executive Director
5,000 +3.2%
6.40
US$32,000 		5,000 +3.2% 6.40 US$32,000
2023-10-11 2023-10-10 B Purchase
2.7
Mendelson Daniel Newman
Non-Executive Director
1,100 +0.7%
6.41
US$7,051 		1,100 +0.7% 6.41 US$7,051
2023-10-10 2023-10-06 B Purchase
2.7
Mendelson Daniel Newman
Non-Executive Director
1,530 +1.0%
6.48
US$9,914 		1,530 +1.0% 6.48 US$9,914
2023-10-06 2023-10-05 B Purchase
2.7
Mendelson Daniel Newman
Non-Executive Director
2,000 +1.3%
6.47
US$12,940 		2,000 +1.3% 6.47 US$12,940
2023-10-04 2023-10-04 B Purchase
2.7
Mendelson Daniel Newman
Non-Executive Director
5,000 +3.4%
6.40
US$32,000 		5,000 +3.4% 6.40 US$32,000
2023-10-04 2023-10-03 B Purchase
2.7
Mendelson Daniel Newman
Non-Executive Director
2,500 +1.7%
6.30
US$15,750 		2,500 +1.7% 6.30 US$15,750
2023-10-16 2023-09-29 B Purchase
2.7
Mendelson Daniel Newman
Non-Executive Director
4,000 +2.4%
6.16
US$24,640 		4,000 +2.4% 6.16 US$24,640
2023-10-16 2023-09-28 B Purchase
2.7
Mendelson Daniel Newman
Non-Executive Director
5,000 +3.0%
6.22
US$31,100 		5,000 +3.0% 6.22 US$31,100
2023-10-16 2023-09-27 B Purchase
2.7
Mendelson Daniel Newman
Non-Executive Director
1,500 +0.9%
5.95
US$8,925 		1,500 +0.9% 5.95 US$8,925
2023-09-27 2023-09-26 B Purchase
2.7
Mendelson Daniel Newman
Non-Executive Director
5,000 +3.5%
5.65
US$28,250 		5,000 +3.5% 5.65 US$28,250
2023-09-25 2023-09-22 B Purchase
2.7
Mendelson Daniel Newman
Non-Executive Director
3,812 +2.8%
5.50
US$20,966 		3,812 +2.8% 5.50 US$20,966
2023-09-25 2023-09-21 B Purchase
2.7
Mendelson Daniel Newman
Non-Executive Director
5,000 +3.8%
5.51
US$27,550 		5,000 +3.8% 5.51 US$27,550
2023-09-25 2023-09-20 B Purchase
2.7
Mendelson Daniel Newman
Non-Executive Director
4,018 +3.1%
5.51
US$22,139 		4,018 +3.1% 5.51 US$22,139
2023-09-25 2023-09-19 B Purchase
2.7
Mendelson Daniel Newman
Non-Executive Director
5,000 +4.1%
5.28
US$26,400 		5,000 +4.1% 5.28 US$26,400
2023-03-21 2023-03-17 B Purchase
3.0
Morris Ronnie

CEO

Executive Director
12,382 +1.5%
4.04
US$49,969 		12,382 +1.5% 4.04 US$49,969
2020-12-17 2020-12-16 S Sale
1.9
Breitfeld Philip P.
Non-Executive Director
31,443 -100.0%
11.35
US$356,976 		31,443 -100.0% 11.35 US$356,976
2020-03-30 2020-03-26 B Purchase
2.7
Mendelson Daniel Newman
Non-Executive Director
300 +0.5%
5.89
US$1,767 		300 +0.5% 5.89 US$1,767
2020-03-30 2020-03-26 B Purchase
2.7
Mendelson Daniel Newman
Non-Executive Director
700 +1.2%
5.90
US$4,130 		700 +1.2% 5.90 US$4,130
2020-03-30 2020-03-26 B Purchase
2.7
Mendelson Daniel Newman
Non-Executive Director
100 +0.2%
5.97
US$597 		100 +0.2% 5.97 US$597
2020-03-30 2020-03-26 B Purchase
2.7
Mendelson Daniel Newman
Non-Executive Director
100 +0.2%
5.99
US$599 		100 +0.2% 5.99 US$599
2020-03-30 2020-03-26 B Purchase
2.7
Mendelson Daniel Newman
Non-Executive Director
20 +0.0%
6.00
US$120 		20 +0.0% 6.00 US$120
2020-03-26 2020-03-24 B Purchase
2.7
Mendelson Daniel Newman
Non-Executive Director
26 +0.0%
5.50
US$143 		26 +0.0% 5.50 US$143
2020-03-26 2020-03-24 S Sale
3.0
Morris Ronnie

CEO

Executive Director
75 -0.0%
5.25
US$394 		75 -0.0% 5.25 US$394
2020-03-24 2020-03-20 B Purchase
3.0
Morris Ronnie

CEO

Executive Director
75 +0.0%
4.75
US$356 		75 +0.0% 4.75 US$356
2020-03-10 2020-03-06 S Sale
2.4
New Enterprise Associates 14, L.P.
Large shareholder
708,155 -29.2%
6.99
US$4,950,003 		708,155 -29.2% 6.99 US$4,950,003
2018-12-20 2018-12-19 B Purchase
4.0
Morris Ronnie

CEO

Executive Director
20,000 +2.5%
7.44
US$148,800 		20,000 +2.5% 7.44 US$148,800
2018-11-08 2018-11-06 S Sale Mendelson Daniel Newman Non-Executive Director
5,000 -8.0%
13.75
US$68,750 		5,000 -8.0% 13.75 US$68,750
2018-10-03 2018-10-01 S Sale
2.9
ACKERMAN JOEL
Non-Executive Director
22,535 -2.2%
17.02
US$383,546 		22,535 -2.2% 17.02 US$383,546
2018-10-05 2018-09-20 S Sale Mendelson Daniel Newman Non-Executive Director
8,333 -11.8%
13.02
US$108,496 		8,333 -11.8% 13.02 US$108,496
2018-03-28 2018-03-27 B Purchase
4.0
Morris Ronnie

CEO

Executive Director
2,300 +0.2%
3.62
US$8,319 		2,300 +0.2% 3.62 US$8,319
2018-03-28 2018-03-26 B Purchase
4.0
Morris Ronnie

CEO

Executive Director
2,235 +0.2%
3.57
US$7,979 		2,235 +0.2% 3.57 US$7,979
2018-03-26 2018-03-23 B Purchase
4.0
Morris Ronnie

CEO

Executive Director
440 +0.0%
3.50
US$1,540 		440 +0.0% 3.50 US$1,540
2018-03-26 2018-03-22 B Purchase
4.0
Morris Ronnie

CEO

Executive Director
200 +0.0%
3.48
US$696 		200 +0.0% 3.48 US$696
2018-03-26 2018-03-22 B Purchase
4.0
Morris Ronnie

CEO

Executive Director
60 +0.0%
3.50
US$210 		60 +0.0% 3.50 US$210
2016-10-24 2016-10-21 B Purchase
4.0
Morris Ronnie

President

Executive Director
10,000 +0.9%
1.68
US$16,800 		10,000 +0.9% 1.68 US$16,800
2016-10-24 2016-10-21 B Purchase
4.0
Morris Ronnie

President

Executive Director
10,000 +0.9%
1.67
US$16,700 		10,000 +0.9% 1.67 US$16,700
2016-10-24 2016-10-21 B Purchase
4.0
Morris Ronnie

President

Executive Director
10,000 +0.9%
1.64
US$16,400 		10,000 +0.9% 1.64 US$16,400
2016-10-20 2016-10-19 B Purchase
4.0
Morris Ronnie

President

Executive Director
10,000 +0.9%
1.70
US$17,000 		10,000 +0.9% 1.70 US$17,000
2016-10-20 2016-10-18 B Purchase
2.9
ACKERMAN JOEL

Chief Executive Officer

Executive Director
418 +0.0%
1.70
US$711 		418 +0.0% 1.70 US$711
2016-10-20 2016-10-18 B Purchase
2.9
ACKERMAN JOEL

Chief Executive Officer

Executive Director
381 +0.0%
1.69
US$644 		381 +0.0% 1.69 US$644
2016-10-20 2016-10-18 B Purchase
2.9
ACKERMAN JOEL

Chief Executive Officer

Executive Director
201 +0.0%
1.69
US$340 		201 +0.0% 1.69 US$340
2016-10-20 2016-10-18 B Purchase
2.9
ACKERMAN JOEL

Chief Executive Officer

Executive Director
1,000 +0.1%
1.70
US$1,698 		1,000 +0.1% 1.70 US$1,698
2016-10-17 2016-10-14 B Purchase
4.0
Morris Ronnie

President

Executive Director
10,000 +0.9%
1.66
US$16,600 		10,000 +0.9% 1.66 US$16,600
2016-10-17 2016-10-14 B Purchase
4.0
Morris Ronnie

President

Executive Director
305 +0.0%
1.66
US$506 		305 +0.0% 1.66 US$506
2016-10-14 2016-10-14 B Purchase
2.9
ACKERMAN JOEL

Chief Executive Officer

Executive Director
300 +0.0%
1.65
US$495 		300 +0.0% 1.65 US$495
2016-10-14 2016-10-14 B Purchase
2.9
ACKERMAN JOEL

Chief Executive Officer

Executive Director
1,000 +0.1%
1.66
US$1,658 		1,000 +0.1% 1.66 US$1,658
2016-10-14 2016-10-13 B Purchase
4.0
Morris Ronnie

President

Executive Director
9,695 +0.9%
1.66
US$16,094 		9,695 +0.9% 1.66 US$16,094
2016-10-14 2016-10-13 B Purchase
4.0
Morris Ronnie

President

Executive Director
5,643 +0.5%
1.66
US$9,367 		5,643 +0.5% 1.66 US$9,367
2016-10-14 2016-10-13 B Purchase
4.0
Morris Ronnie

President

Executive Director
4,357 +0.4%
1.66
US$7,233 		4,357 +0.4% 1.66 US$7,233
2016-10-14 2016-10-13 B Purchase
2.9
ACKERMAN JOEL

Chief Executive Officer

Executive Director
1,000 +0.1%
1.67
US$1,670 		1,000 +0.1% 1.67 US$1,670
2016-10-14 2016-10-13 B Purchase
2.9
ACKERMAN JOEL

Chief Executive Officer

Executive Director
1,000 +0.1%
1.68
US$1,679 		1,000 +0.1% 1.68 US$1,679
2016-10-14 2016-10-13 B Purchase
2.9
ACKERMAN JOEL

Chief Executive Officer

Executive Director
1,000 +0.1%
1.68
US$1,677 		1,000 +0.1% 1.68 US$1,677
2016-10-14 2016-10-13 B Purchase
2.9
ACKERMAN JOEL

Chief Executive Officer

Executive Director
1,000 +0.1%
1.67
US$1,670 		1,000 +0.1% 1.67 US$1,670
2016-10-14 2016-10-13 B Purchase
2.9
ACKERMAN JOEL

Chief Executive Officer

Executive Director
1,000 +0.1%
1.67
US$1,670 		1,000 +0.1% 1.67 US$1,670
2016-10-14 2016-10-13 B Purchase
2.9
ACKERMAN JOEL

Chief Executive Officer

Executive Director
500 +0.0%
1.69
US$844 		500 +0.0% 1.69 US$844
2016-10-14 2016-10-13 B Purchase
4.0
Morris Ronnie

President

Executive Director
10,000 +1.0%
1.68
US$16,800 		10,000 +1.0% 1.68 US$16,800
2016-10-14 2016-10-13 B Purchase
2.9
ACKERMAN JOEL

Chief Executive Officer

Executive Director
500 +0.0%
1.68
US$842 		500 +0.0% 1.68 US$842
2016-10-11 2016-10-10 B Purchase
4.0
Morris Ronnie

President

Executive Director
5,000 +0.5%
1.66
US$8,300 		5,000 +0.5% 1.66 US$8,300
2016-10-11 2016-10-10 B Purchase
4.0
Morris Ronnie

President

Executive Director
4,537 +0.4%
1.66
US$7,531 		4,537 +0.4% 1.66 US$7,531
2016-10-07 2016-10-07 B Purchase
2.9
ACKERMAN JOEL

Chief Executive Officer

Executive Director
5,000 +0.5%
1.64
US$8,200 		5,000 +0.5% 1.64 US$8,200
2016-10-07 2016-10-06 B Purchase
2.9
ACKERMAN JOEL

Chief Executive Officer

Executive Director
1,500 +0.1%
1.61
US$2,421 		1,500 +0.1% 1.61 US$2,421
2016-10-07 2016-10-06 B Purchase
2.9
ACKERMAN JOEL

Chief Executive Officer

Executive Director
702 +0.1%
1.62
US$1,137 		702 +0.1% 1.62 US$1,137
2016-10-07 2016-10-06 B Purchase
2.9
ACKERMAN JOEL

Chief Executive Officer

Executive Director
1,000 +0.1%
1.61
US$1,611 		1,000 +0.1% 1.61 US$1,611
2016-09-26 2016-09-23 B Purchase
2.9
ACKERMAN JOEL

Chief Executive Officer

Executive Director
33 +0.0%
1.65
US$54 		33 +0.0% 1.65 US$54
Explore more

More insider trading research around Champions Oncology Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America